{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:50Z","timestamp":1792686470394,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T00:00:00Z","timestamp":1638489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The anti-angiogenic effects of bisphosphonates have been hypothesized as one of the major etiologic factors in the development of medication-related osteonecrosis of the jaw (MRONJ), a severe debilitating condition with limited treatment options. This study evaluated the potential of a gelatine-hyaluronic acid hydrogel loaded with the angiogenic growth factor, vascular endothelial growth factor (VEGF), as a local delivery system to aid in maintaining vascularization in a bisphosphonate-treated (Zoledronic Acid) rodent maxillary extraction defect. Healing was assessed four weeks after implantation of the VEGF-hydrogel into extraction sockets. Gross examination and histological assessment showed that total osteonecrosis and inflammatory infiltrate was significantly reduced in the presence of VEGF. Also, total vascularity and specifically neovascularization, was significantly improved in animals that received VEGF hydrogel. Gene expression of vascular, inflammatory and bone specific markers within the defect area were also significantly altered in the presence of VEGF. Furthermore, plasma cytokine levels were assessed to determine the systemic effect of locally delivered VEGF and showed similar outcomes. In conclusion, the use of locally delivered VEGF within healing extraction sockets assists bone healing and prevents MRONJ via a pro-angiogenic and immunomodulatory mechanism.<\/jats:p>","DOI":"10.1038\/s41598-021-02637-w","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T06:03:41Z","timestamp":1638511421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw"],"prefix":"10.1038","volume":"11","author":[{"given":"Dileep","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hamlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedryck","family":"Vaquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugen Bogdan","family":"Petcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poornima","family":"Ramamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saso","family":"Ivanovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,3]]},"reference":[{"key":"2637_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell, R. G., Watts, N. B., Ebetino, F. H. & Rogers, M. J. Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy. Osteoporos. Int. 19, 733\u2013759. https:\/\/doi.org\/10.1007\/s00198-007-0540-8 (2008).","journal-title":"Osteoporos. Int."},{"key":"2637_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/cncr.21130","volume":"104","author":"CA Migliorati","year":"2005","unstructured":"Migliorati, C. A., Schubert, M. M., Peterson, D. E. & Seneda, L. M. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive cancer therapy. Cancer 104, 83\u201393. https:\/\/doi.org\/10.1002\/cncr.21130 (2005).","journal-title":"Cancer"},{"key":"2637_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.tripleo.2005.10.045","volume":"102","author":"AF Leite","year":"2006","unstructured":"Leite, A. F. et al. Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102, 14\u201321. https:\/\/doi.org\/10.1016\/j.tripleo.2005.10.045 (2006).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"2637_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1600-0714.2007.00607.x","volume":"37","author":"B Malmgren","year":"2008","unstructured":"Malmgren, B., Astrom, E. & Soderhall, S. No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates. J. Oral Pathol. Med. 37, 196\u2013200. https:\/\/doi.org\/10.1111\/j.1600-0714.2007.00607.x (2008).","journal-title":"J. Oral Pathol. Med."},{"key":"2637_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","volume":"45","author":"P Lesclous","year":"2009","unstructured":"Lesclous, P. et al. Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation?. Bone 45, 843\u2013852. https:\/\/doi.org\/10.1016\/j.bone.2009.07.011 (2009).","journal-title":"Bone"},{"key":"2637_CR6","first-page":"173","volume-title":"Zoledronic Acid: Clinical Uses, Therapeutic Effects and Pharmacokinetics","author":"D Sharma","year":"2014","unstructured":"Sharma, D., Hamlet, S., Petcu, E. B. & Ivanovski, S. In Zoledronic Acid: Clinical Uses, Therapeutic Effects and Pharmacokinetics (ed. Carman, R.) 173\u2013192 (Nova Science, 2014)."},{"key":"2637_CR7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","volume":"22","author":"S Khosla","year":"2007","unstructured":"Khosla, S. et al. Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 22, 1479\u20131491. https:\/\/doi.org\/10.1359\/jbmr.0707onj (2007).","journal-title":"J. Bone Miner. Res."},{"key":"2637_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/s0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx, R. E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J. Oral Maxillofac Surg. 61, 1115\u20131117. https:\/\/doi.org\/10.1016\/s0278-2391(03)00720-1 (2003).","journal-title":"J. Oral Maxillofac Surg."},{"key":"2637_CR9","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero, S. L. et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J. Oral Maxillofac Surg. 72, 1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031 (2014).","journal-title":"J. Oral Maxillofac Surg."},{"key":"2637_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000313787","volume":"124","author":"A Allegra","year":"2010","unstructured":"Allegra, A. et al. Bisphosphonates induce apoptosis of circulating endothelial cells in multiple myeloma patients and in subjects with bisphosphonate-induced osteonecrosis of the jaws. Acta Haematol. 124, 79\u201385. https:\/\/doi.org\/10.1159\/000313787 (2010).","journal-title":"Acta Haematol."},{"key":"2637_CR11","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1902\/jop.2008.080041","volume":"79","author":"BO Cetinkaya","year":"2008","unstructured":"Cetinkaya, B. O., Keles, G. C., Ayas, B. & Gurgor, P. Effects of risedronate on alveolar bone loss and angiogenesis: A stereologic study in rats. J. Periodontol. 79, 1950\u20131961. https:\/\/doi.org\/10.1902\/jop.2008.080041 (2008).","journal-title":"J. Periodontol."},{"key":"2637_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1471-2474-12-146","volume":"12","author":"D Fu","year":"2011","unstructured":"Fu, D. et al. Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro. BMC Musculoskelet. Disord. 12, 146. https:\/\/doi.org\/10.1186\/1471-2474-12-146 (2011).","journal-title":"BMC Musculoskelet. Disord."},{"key":"2637_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00784-013-1060-x","volume":"18","author":"AM Pabst","year":"2014","unstructured":"Pabst, A. M., Ziebart, T., Ackermann, M., Konerding, M. A. & Walter, C. Bisphosphonates\u2019 antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: Influence on microvessel sprouting in an in vivo 3D Matrigel assay. Clin. Oral Invest. 18, 1015\u20131022. https:\/\/doi.org\/10.1007\/s00784-013-1060-x (2014).","journal-title":"Clin. Oral Invest."},{"key":"2637_CR14","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000347226","volume":"85","author":"D Santini","year":"2013","unstructured":"Santini, D. et al. Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. Oncology 85, 342\u2013347. https:\/\/doi.org\/10.1159\/000347226 (2013).","journal-title":"Oncology"},{"key":"2637_CR15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood, J. et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J. Pharmacol. Exp. Ther. 302, 1055\u20131061. https:\/\/doi.org\/10.1124\/jpet.102.035295 (2002).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2637_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.mehy.2010.10.036","volume":"76","author":"G Yin","year":"2011","unstructured":"Yin, G., Bai, Y. & Luo, E. Angiogenic suppression of osteoclasts may play a role in developing bisphosphonate-related osteonecrosis of the jaw. Med. Hypotheses 76, 347\u2013349. https:\/\/doi.org\/10.1016\/j.mehy.2010.10.036 (2011).","journal-title":"Med. Hypotheses"},{"key":"2637_CR17","doi-asserted-by":"publisher","first-page":"20580","DOI":"10.1038\/srep20580","volume":"6","author":"D Sharma","year":"2016","unstructured":"Sharma, D., Hamlet, S. M., Petcu, E. B. & Ivanovski, S. The effect of bisphosphonates on the endothelial differentiation of mesenchymal stem cells. Sci. Rep. 6, 20580. https:\/\/doi.org\/10.1038\/srep20580 (2016).","journal-title":"Sci. Rep."},{"key":"2637_CR18","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.4317\/medoral.17150","volume":"16","author":"M Ali-Erdem","year":"2011","unstructured":"Ali-Erdem, M. et al. Extraction socket healing in rats treated with bisphosphonate: Animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients. Med. Oral Patol. Oral Cir Bucal. 16, e879-883. https:\/\/doi.org\/10.4317\/medoral.17150 (2011).","journal-title":"Med. Oral Patol. Oral Cir Bucal."},{"key":"2637_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/odi.12067","volume":"19","author":"D Sharma","year":"2013","unstructured":"Sharma, D., Hamlet, S., Petcu, E. & Ivanovski, S. Animal models for bisphosphonate-related osteonecrosis of the jaws: An appraisal. Oral Dis. 19, 747\u2013754. https:\/\/doi.org\/10.1111\/odi.12067 (2013).","journal-title":"Oral Dis."},{"key":"2637_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/odi.12355","volume":"21","author":"H Choi","year":"2015","unstructured":"Choi, H. et al. Genetic association between VEGF polymorphisms and BRONJ in the Korean population. Oral Dis. 21, 866\u2013871. https:\/\/doi.org\/10.1111\/odi.12355 (2015).","journal-title":"Oral Dis."},{"key":"2637_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1006\/bbrc.1994.1240","volume":"199","author":"V Midy","year":"1994","unstructured":"Midy, V. & Plouet, J. Vasculotropin\/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199, 380\u2013386. https:\/\/doi.org\/10.1006\/bbrc.1994.1240 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2637_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1749-799X-4-19","volume":"4","author":"J Street","year":"2009","unstructured":"Street, J. & Lenehan, B. Vascular endothelial growth factor regulates osteoblast survival: Evidence for an autocrine feedback mechanism. J. Orthop. Surg. Res. 4, 19. https:\/\/doi.org\/10.1186\/1749-799X-4-19 (2009).","journal-title":"J. Orthop. Surg. Res."},{"issue":"Pt1","key":"2637_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1242\/jcs.113.1.59","volume":"113","author":"MF Carlevaro","year":"2000","unstructured":"Carlevaro, M. F., Cermelli, S., Cancedda, R. & Descalzi Cancedda, F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: Auto-paracrine role during endochondral bone formation. J. Cell. Sci. 113(Pt1), 59\u201369 (2000).","journal-title":"J. Cell. Sci."},{"key":"2637_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/9467","volume":"5","author":"HP Gerber","year":"1999","unstructured":"Gerber, H. P. et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5, 623\u2013628. https:\/\/doi.org\/10.1038\/9467 (1999).","journal-title":"Nat. Med."},{"key":"2637_CR25","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.bone.2012.05.008","volume":"51","author":"EF Morgan","year":"2012","unstructured":"Morgan, E. F. et al. Vascular development during distraction osteogenesis proceeds by sequential intramuscular arteriogenesis followed by intraosteal angiogenesis. Bone 51, 535\u2013545. https:\/\/doi.org\/10.1016\/j.bone.2012.05.008 (2012).","journal-title":"Bone"},{"key":"2637_CR26","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.biomaterials.2006.11.050","volume":"28","author":"J Kim","year":"2007","unstructured":"Kim, J. et al. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28, 1830\u20131837. https:\/\/doi.org\/10.1016\/j.biomaterials.2006.11.050 (2007).","journal-title":"Biomaterials"},{"key":"2637_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bone.2013.11.019","volume":"59","author":"MS Bae","year":"2014","unstructured":"Bae, M. S. et al. Photo-cured hyaluronic acid-based hydrogels containing growth and differentiation factor 5 (GDF-5) for bone tissue regeneration. Bone 59, 189\u2013198. https:\/\/doi.org\/10.1016\/j.bone.2013.11.019 (2014).","journal-title":"Bone"},{"key":"2637_CR28","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1016\/j.actbio.2011.04.018","volume":"7","author":"X Xu","year":"2011","unstructured":"Xu, X., Jha, A. K., Duncan, R. L. & Jia, X. Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. Acta Biomater. 7, 3050\u20133059. https:\/\/doi.org\/10.1016\/j.actbio.2011.04.018 (2011).","journal-title":"Acta Biomater."},{"key":"2637_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ydbio.2007.02.023","volume":"305","author":"Y Li","year":"2007","unstructured":"Li, Y., Toole, B. P., Dealy, C. N. & Kosher, R. A. Hyaluronan in limb morphogenesis. Dev. Biol. 305, 411\u2013420. https:\/\/doi.org\/10.1016\/j.ydbio.2007.02.023 (2007).","journal-title":"Dev. Biol."},{"key":"2637_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1046\/j.1365-2796.1997.00171.x","volume":"242","author":"BP Toole","year":"1997","unstructured":"Toole, B. P. Hyaluronan in morphogenesis. J. Intern. Med. 242, 35\u201340 (1997).","journal-title":"J. Intern. Med."},{"key":"2637_CR31","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0142-9612(99)00006-X","volume":"20","author":"LS Liu","year":"1999","unstructured":"Liu, L. S., Thompson, A. Y., Heidaran, M. A., Poser, J. W. & Spiro, R. C. An osteoconductive collagen\/hyaluronate matrix for bone regeneration. Biomaterials 20, 1097\u20131108 (1999).","journal-title":"Biomaterials"},{"key":"2637_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.tdj.2014.07.001","volume":"11","author":"WAO Segari","year":"2014","unstructured":"Segari, W. A. O., El Khalek Radwan, D. A. & Abd El Hamid, M. A. The effect of adding hyaluronic acid to calcium phosphate on periapical tissue healing following periradicular surgery in dogs. Tanta Dental J. 11, 122\u2013129. https:\/\/doi.org\/10.1016\/j.tdj.2014.07.001 (2014).","journal-title":"Tanta Dental J."},{"key":"2637_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3892\/br.2014.389","volume":"3","author":"C Walter","year":"2015","unstructured":"Walter, C., Pabst, A. M. & Ziebart, T. Effects of a low-level diode laser on oral keratinocytes, oral fibroblasts, endothelial cells and osteoblasts incubated with bisphosphonates: An study. Biomed. Rep. 3, 14\u201318. https:\/\/doi.org\/10.3892\/br.2014.389 (2015).","journal-title":"Biomed. Rep."},{"key":"2637_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.tripleo.2011.04.020","volume":"112","author":"G Subramanian","year":"2011","unstructured":"Subramanian, G., Cohen, H. V. & Quek, S. Y. A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide\u2019s potential role in its resolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 112, 744\u2013753. https:\/\/doi.org\/10.1016\/j.tripleo.2011.04.020 (2011).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"2637_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.bone.2014.12.021","volume":"73","author":"T Ikeda","year":"2015","unstructured":"Ikeda, T. et al. Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: New strategies for the treatment of BRONJ. Bone 73, 217\u2013222. https:\/\/doi.org\/10.1016\/j.bone.2014.12.021 (2015).","journal-title":"Bone"},{"key":"2637_CR36","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1007\/s00125-005-1951-8","volume":"48","author":"RM Perrin","year":"2005","unstructured":"Perrin, R. M. et al. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor. Diabetologia 48, 2422\u20132427. https:\/\/doi.org\/10.1007\/s00125-005-1951-8 (2005).","journal-title":"Diabetologia"},{"key":"2637_CR37","doi-asserted-by":"publisher","first-page":"9656","DOI":"10.1073\/pnas.152324099","volume":"99","author":"J Street","year":"2002","unstructured":"Street, J. et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc. Natl. Acad. Sci. U S A 99, 9656\u20139661. https:\/\/doi.org\/10.1073\/pnas.152324099 (2002).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"2637_CR38","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1016\/S0142-9612(00)00120-4","volume":"21","author":"WL Murphy","year":"2000","unstructured":"Murphy, W. L., Peters, M. C., Kohn, D. H. & Mooney, D. J. Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 21, 2521\u20132527 (2000).","journal-title":"Biomaterials"},{"key":"2637_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1034\/j.1600-051X.2003.300203.x","volume":"30","author":"H Jentsch","year":"2003","unstructured":"Jentsch, H., Pomowski, R., Kundt, G. & Gocke, R. Treatment of gingivitis with hyaluronan. J. Clin. Periodontol. 30, 159\u2013164 (2003).","journal-title":"J. Clin. Periodontol."},{"key":"2637_CR40","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1902\/jop.2003.74.2.262","volume":"74","author":"GP Prato","year":"2003","unstructured":"Prato, G. P. et al. An autologous cell hyaluronic acid graft technique for gingival augmentation: A case series. J. Periodontol. 74, 262\u2013267. https:\/\/doi.org\/10.1902\/jop.2003.74.2.262 (2003).","journal-title":"J. Periodontol."},{"key":"2637_CR41","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1600-0501.2006.01303.x","volume":"18","author":"Z Schwartz","year":"2007","unstructured":"Schwartz, Z. et al. Clinical evaluation of demineralized bone allograft in a hyaluronic acid carrier for sinus lift augmentation in humans: A computed tomography and histomorphometric study. Clin. Oral Implants Res. 18, 204\u2013211. https:\/\/doi.org\/10.1111\/j.1600-0501.2006.01303.x (2007).","journal-title":"Clin. Oral Implants Res."},{"key":"2637_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.7150\/ijms.6.65","volume":"6","author":"A Ballini","year":"2009","unstructured":"Ballini, A., Cantore, S., Capodiferro, S. & Grassi, F. R. Esterified hyaluronic acid and autologous bone in the surgical correction of the infra-bone defects. Int. J. Med. Sci 6, 65\u201371 (2009).","journal-title":"Int. J. Med. Sci"},{"key":"2637_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1756-8722-5-56","volume":"5","author":"B Vincenzi","year":"2012","unstructured":"Vincenzi, B. et al. Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw. J. Hematol. Oncol. 5, 56. https:\/\/doi.org\/10.1186\/1756-8722-5-56 (2012).","journal-title":"J. Hematol. Oncol."},{"key":"2637_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.120671","volume":"269","author":"C Vaquette","year":"2021","unstructured":"Vaquette, C., Mitchell, J., Fernandez-Medina, T., Kumar, S. & Ivanovski, S. Resorbable additively manufactured scaffold imparts dimensional stability to extraskeletally regenerated bone. Biomaterials 269, 120671. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.120671 (2021).","journal-title":"Biomaterials"},{"key":"2637_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1134\/S1990750821020050","volume":"15","author":"LS Litvinova","year":"2021","unstructured":"Litvinova, L. S. et al. Osteogenic and angiogenic properties of heparin as a system for delivery of biomolecules for bone bioengineering: A brief critical review. Biochem. Mosc. Suppl. B 15, 147\u2013152. https:\/\/doi.org\/10.1134\/S1990750821020050 (2021).","journal-title":"Biochem. Mosc. Suppl. B"},{"key":"2637_CR46","doi-asserted-by":"publisher","first-page":"3027303","DOI":"10.1155\/2019\/3027303","volume":"2019","author":"H Li","year":"2019","unstructured":"Li, H. et al. The application of hyaluronic acid-based hydrogels in bone and cartilage tissue engineering. Adv. Mater. Sci. Eng. 2019, 3027303. https:\/\/doi.org\/10.1155\/2019\/3027303 (2019).","journal-title":"Adv. Mater. Sci. Eng."},{"key":"2637_CR47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/ard.54.5.429","volume":"54","author":"TC Laurent","year":"1995","unstructured":"Laurent, T. C., Laurent, U. B. & Fraser, J. R. Functions of hyaluronan. Ann. Rheum. Dis. 54, 429\u2013432 (1995).","journal-title":"Ann. Rheum. Dis."},{"key":"2637_CR48","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.biomaterials.2012.11.003","volume":"34","author":"C Cardemil","year":"2013","unstructured":"Cardemil, C., Omar, O. M., Norlindh, B., Wexell, C. L. & Thomsen, P. The effects of a systemic single dose of zoledronic acid on post-implantation bone remodelling and inflammation in an ovariectomised rat model. Biomaterials 34, 1546\u20131561. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.11.003 (2013).","journal-title":"Biomaterials"},{"key":"2637_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000087286","volume":"69","author":"G Ferretti","year":"2005","unstructured":"Ferretti, G. et al. Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients. Oncology 69, 35\u201343. https:\/\/doi.org\/10.1159\/000087286 (2005).","journal-title":"Oncology"},{"key":"2637_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.201900226","volume":"19","author":"GI Brierly","year":"2019","unstructured":"Brierly, G. I. et al. Investigation of sustained BMP delivery in the prevention of medication-related osteonecrosis of the jaw (MRONJ) in a rat model. Macromol. Biosci. 19, e1900226. https:\/\/doi.org\/10.1002\/mabi.201900226 (2019).","journal-title":"Macromol. Biosci."},{"key":"2637_CR51","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1096\/fj.02-0634rev","volume":"17","author":"SE Duff","year":"2003","unstructured":"Duff, S. E., Li, C., Garland, J. M. & Kumar, S. CD105 is important for angiogenesis: Evidence and potential applications. FASEB J. 17, 984\u2013992. https:\/\/doi.org\/10.1096\/fj.02-0634rev (2003).","journal-title":"FASEB J."},{"key":"2637_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/(SICI)1096-9896(199604)178:4<363::AID-PATH491>3.0.CO;2-8","volume":"178","author":"P Kumar","year":"1996","unstructured":"Kumar, P., Wang, J. M. & Bernabeu, C. CD 105 and angiogenesis. J. Pathol. 178, 363\u2013366. https:\/\/doi.org\/10.1002\/(SICI)1096-9896(199604)178:4%3c363::AID-PATH491%3e3.0.CO;2-8 (1996).","journal-title":"J. Pathol."},{"key":"2637_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/PL00012413","volume":"51","author":"E Torsney","year":"2002","unstructured":"Torsney, E., Charlton, R., Parums, D., Collis, M. & Arthur, H. M. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm. Res. 51, 464\u2013470 (2002).","journal-title":"Inflamm. Res."},{"key":"2637_CR54","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2133.2011.10327.x","volume":"165","author":"M Valluru","year":"2011","unstructured":"Valluru, M., Brown, N. J., Cross, S. S., Reed, M. W. & Staton, C. A. Blood vessel characterization in human dermal wound repair and scarring. Br. J. Dermatol. 165, 221\u2013224. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10327.x (2011).","journal-title":"Br. J. Dermatol."},{"key":"2637_CR55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.tripleo.2011.02.028","volume":"112","author":"F Wehrhan","year":"2011","unstructured":"Wehrhan, F. et al. Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 112, 216\u2013221. https:\/\/doi.org\/10.1016\/j.tripleo.2011.02.028 (2011).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"2637_CR56","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1177\/1947601911423031","volume":"2","author":"M Shibuya","year":"2011","unstructured":"Shibuya, M. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: A crucial target for anti- and pro-angiogenic therapies. Genes Cancer 2, 1097\u20131105. https:\/\/doi.org\/10.1177\/1947601911423031 (2011).","journal-title":"Genes Cancer"},{"key":"2637_CR57","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","volume":"20","author":"T Takahashi","year":"2001","unstructured":"Takahashi, T., Yamaguchi, S., Chida, K. & Shibuya, M. A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768\u20132778. https:\/\/doi.org\/10.1093\/emboj\/20.11.2768 (2001).","journal-title":"EMBO J."},{"key":"2637_CR58","doi-asserted-by":"publisher","first-page":"23217","DOI":"10.1074\/jbc.M109.019679","volume":"284","author":"Y Xiong","year":"2009","unstructured":"Xiong, Y. et al. Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways. J. Biol. Chem. 284, 23217\u201323224. https:\/\/doi.org\/10.1074\/jbc.M109.019679 (2009).","journal-title":"J. Biol. Chem."},{"key":"2637_CR59","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41598-018-37063-y","volume":"9","author":"LF Toro","year":"2019","unstructured":"Toro, L. F. et al. Application of autologous platelet-rich plasma on tooth extraction site prevents occurence of medication-related osteonecrosis of the jaws in rats. Sci. Rep. 9, 22. https:\/\/doi.org\/10.1038\/s41598-018-37063-y (2019).","journal-title":"Sci. Rep."},{"key":"2637_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132520","volume":"10","author":"RN Howie","year":"2015","unstructured":"Howie, R. N. et al. A model for osteonecrosis of the jaw with zoledronate treatment following repeated major trauma. PLoS ONE 10, e0132520. https:\/\/doi.org\/10.1371\/journal.pone.0132520 (2015).","journal-title":"PLoS ONE"},{"key":"2637_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214173","volume":"14","author":"CC Biguetti","year":"2019","unstructured":"Biguetti, C. C. et al. Medication-related osteonecrosis of the jaws after tooth extraction in senescent female mice treated with zoledronic acid: Microtomographic, histological and immunohistochemical characterization. PLoS ONE 14, e0214173. https:\/\/doi.org\/10.1371\/journal.pone.0214173 (2019).","journal-title":"PLoS ONE"},{"key":"2637_CR62","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5125\/jkaoms.2016.42.5.271","volume":"42","author":"SJ Paek","year":"2016","unstructured":"Paek, S. J. et al. Diseases having an influence on inhibition of angiogenesis as risk factors of osteonecrosis of the jaw. J. Korean Assoc. Oral Maxillofac Surg. 42, 271\u2013277. https:\/\/doi.org\/10.5125\/jkaoms.2016.42.5.271 (2016).","journal-title":"J. Korean Assoc. Oral Maxillofac Surg."},{"key":"2637_CR63","volume-title":"ASH 2013 Multiple Myeloma Gateway","author":"A Badros","year":"2013","unstructured":"Badros, A. et al. ASH 2013 Multiple Myeloma Gateway (Beacon Press, 2013)."},{"key":"2637_CR64","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.cell.2007.06.054","volume":"130","author":"S Lee","year":"2007","unstructured":"Lee, S. et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691\u2013703. https:\/\/doi.org\/10.1016\/j.cell.2007.06.054 (2007).","journal-title":"Cell"},{"key":"2637_CR65","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0140-6736(88)90185-7","volume":"2","author":"JA Eastgate","year":"1988","unstructured":"Eastgate, J. A. et al. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 2, 706\u2013709 (1988).","journal-title":"Lancet"},{"key":"2637_CR66","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/ijos.2014.46","volume":"6","author":"S Pushalkar","year":"2014","unstructured":"Pushalkar, S. et al. Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw. Int. J. Oral Sci. 6, 219\u2013226. https:\/\/doi.org\/10.1038\/ijos.2014.46 (2014).","journal-title":"Int. J. Oral Sci."},{"key":"2637_CR67","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1189\/jlb.0609385","volume":"86","author":"G Solinas","year":"2009","unstructured":"Solinas, G., Germano, G., Mantovani, A. & Allavena, P. Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J. Leukoc. Biol. 86, 1065\u20131073. https:\/\/doi.org\/10.1189\/jlb.0609385 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"2637_CR68","doi-asserted-by":"publisher","first-page":"16163","DOI":"10.1074\/jbc.M412713200","volume":"280","author":"MS Kim","year":"2005","unstructured":"Kim, M. S., Day, C. J. & Morrison, N. A. MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J. Biol. Chem. 280, 16163\u201316169. https:\/\/doi.org\/10.1074\/jbc.M412713200 (2005).","journal-title":"J. Biol. Chem."},{"key":"2637_CR69","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bone.2014.03.005","volume":"63","author":"T Ohba","year":"2014","unstructured":"Ohba, T. et al. Pleiotropic effects of bisphosphonates on osteosarcoma. Bone 63, 110\u2013120. https:\/\/doi.org\/10.1016\/j.bone.2014.03.005 (2014).","journal-title":"Bone"},{"key":"2637_CR70","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.intimp.2009.05.010","volume":"9","author":"T Masuda","year":"2009","unstructured":"Masuda, T., Deng, X. & Tamai, R. Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha (MIP-1alpha) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation. Int. Immunopharmacol. 9, 1115\u20131121. https:\/\/doi.org\/10.1016\/j.intimp.2009.05.010 (2009).","journal-title":"Int. Immunopharmacol."},{"key":"2637_CR71","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/ger.12416","volume":"36","author":"S Kuroshima","year":"2019","unstructured":"Kuroshima, S., Sasaki, M., Murata, H. & Sawase, T. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis. Gerodontology 36, 313\u2013324. https:\/\/doi.org\/10.1111\/ger.12416 (2019).","journal-title":"Gerodontology"},{"key":"2637_CR72","doi-asserted-by":"publisher","DOI":"10.1590\/1678-7757-2020-0204","volume":"28","author":"GZ Ferreira","year":"2020","unstructured":"Ferreira, G. Z. et al. Delayed alveolar bone repair and osteonecrosis associated with Zoledronic Acid therapy in rats: Macroscopic, microscopic and molecular analysis. J. Appl. Oral Sci. 28, e20200204. https:\/\/doi.org\/10.1590\/1678-7757-2020-0204 (2020).","journal-title":"J. Appl. Oral Sci."},{"key":"2637_CR73","doi-asserted-by":"publisher","DOI":"10.1590\/1807-3107bor-2017.vol31.0099","volume":"31","author":"JS Oh","year":"2017","unstructured":"Oh, J. S. & Kim, S. G. Collagen sponge and rhBMP-2 improve socket healing in rats treated with zoledronic acid. Braz. Oral Res. 31, e99. https:\/\/doi.org\/10.1590\/1807-3107bor-2017.vol31.0099 (2017).","journal-title":"Braz. Oral Res."},{"key":"2637_CR74","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1600-0773.1991.tb01312.x","volume":"69","author":"L Laur\u00e9n","year":"1991","unstructured":"Laur\u00e9n, L., Osterman, T. & Karhi, T. Pharmacokinetics of clodronate after single intravenous, intramuscular and subcutaneous injections in rats. Pharmacol. Toxicol. 69, 365\u2013368. https:\/\/doi.org\/10.1111\/j.1600-0773.1991.tb01312.x (1991).","journal-title":"Pharmacol. Toxicol."},{"key":"2637_CR75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin, J. H. Bisphosphonates: A review of their pharmacokinetic properties. Bone 18, 75\u201385. https:\/\/doi.org\/10.1016\/8756-3282(95)00445-9 (1996).","journal-title":"Bone"},{"key":"2637_CR76","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","volume":"1","author":"S Parasuraman","year":"2010","unstructured":"Parasuraman, S., Raveendran, R. & Kesavan, R. Blood sample collection in small laboratory animals. J. Pharmacol. Pharmacother. 1, 87\u201393. https:\/\/doi.org\/10.4103\/0976-500X.72350 (2010).","journal-title":"J. Pharmacol. Pharmacother."},{"key":"2637_CR77","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","volume":"67","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero, S. L. et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20132009 update. J. Oral Maxillofac Surg. 67, 2\u201312. https:\/\/doi.org\/10.1016\/j.joms.2009.01.009 (2009).","journal-title":"J. Oral Maxillofac Surg."},{"key":"2637_CR78","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.joms.2008.01.038","volume":"66","author":"MR Allen","year":"2008","unstructured":"Allen, M. R. & Burr, D. B. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J. Oral Maxillofac Surg. 66, 987\u2013994. https:\/\/doi.org\/10.1016\/j.joms.2008.01.038 (2008).","journal-title":"J. Oral Maxillofac Surg."},{"key":"2637_CR79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-94-017-9716-0_32","volume-title":"Handbook of Vascular Biology Techniques","author":"D Sharma","year":"2015","unstructured":"Sharma, D., Hamlet, S., Petcu, E. & Ivanovski, S. Handbook of Vascular Biology Techniques 417\u2013426 (Springer, 2015)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02637-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02637-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T10:24:03Z","timestamp":1699871043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02637-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,3]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2637"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02637-w","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/OTJK50","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,3]]},"assertion":[{"value":"15 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23371"}}